MIA syndrome in peritoneal dialysis: Prevention and treatment

Contributions to Nephrology

Volumn 150, Issue , 2006, Pages 135-143

  Shahab, Irum ^a   Nolph, Karl D ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DIALYSIS FLUID;

ATHEROSCLEROSIS; DRUG ANTAGONISM; HUMAN; INFLAMMATION; MALNUTRITION; METABOLISM; PERITONEAL DIALYSIS; PERITONEUM; REVIEW; SYNDROME; TRANSPORT AT THE CELLULAR LEVEL;

ATHEROSCLEROSIS; BIOLOGICAL TRANSPORT; CYTOKINES; DIALYSIS SOLUTIONS; HUMANS; INFLAMMATION; MALNUTRITION; PERITONEAL DIALYSIS; PERITONEUM; SYNDROME;

EID: 33745263250     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000093513     Document Type: Review

References (16)

1. Pecoits-Filho R, Lindholm B, Stenvinkel P: The malnutrition, inflammation, and atherosclerosis (MIA) syndrome - the heart of the matter. Nephrol Dial Transplant 2002;17(suppl 11):28.
2. Kalantar-Zadeh K, Ikizler TA, Block G, et al: Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis 2003;42:864.
3. Wang AY, Woo J, Lam CW, et al: Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrol Dial Transplant 2005;20:1676.
4. Stenvinkel P, Chung SH, Heimbürger O, Lindholm B: Malnutrition, inflammation, and atherosclerosis in peritoneal dialysis patients. Perit Dial Int 2001;21(suppl 3):S157.
5. Aguilera A, Sanchez-Tomero JA, Bajo MA, et al: Malnutrition-inflammation syndrome is associated with endothelial dysfunction in peritoneal dialysis patients. Adv Perit Dial 2003;19:240.
6. Chung SH, Stenvinkel P, Bergström J, Lindholm B: Biocompatibility of new peritoneal dialysis solutions: what can we hope to achieve? Perit Dial Int 2000;20(suppl 5):S57.
7. Ikizler TA: Protein and energy: recommended intake and nutrient supplementation in chronic dialysis patients. Semin Dial 2004;17:471.
8. Avram MM, Fein PA, Bonomini L, et al: Predictors of survival in continuous ambulatory peritoneal dialysis patients: a five-year prospective study. Perit Dial Int 1996;16(suppl 1):S190.
9. Stenvinkel P, Heimbürger O, Lindholm B, et al: Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant 2000;15:953.
10. Stenvinkel P, Lindholm B, Heimbürger O: Novel approaches in an integrated therapy of inflammatory-associated wasting in end-stage renal disease. Semin Dial 2004;17:505.
11. Aguilera A, Bajo MA, Rebollo F, et al: Leptin as a marker of nutrition and cardiovascular risk in peritoneal dialysis patients. Adv Perit Dial 2002;18:212.
12. Stenvinkel P, Lindholm B, Lonnqvist F, et al: Increases in serum leptin levels during peritoneal dialysis are associated with inflammation and a decrease in lean body mass. J Am Soc Nephrol 2000;11:1303.
13. Jacobs P, Glorieux G, Vanholder R: Interleukin/cytokine profiles in haemodialysis and in continuous peritoneal dialysis. Nephrol Dial Transplant 2004;19(suppl 5):V41.
14. Kalantar-Zadeh K, Mehrotra R, Fouque D, Kopple JD: Metabolic acidosis and malnutrition-inflammation complex syndrome in chronic renal failure. Semin Dial 2004;17:455.
15. Burkart J: Metabolic consequences of peritoneal dialysis. Semin Dial 2004;17:498.
16. Finkelstein F, Healy H, Abu-Alfa A, et al: Superiority of icodextrin compared with 4.25% dextrose for peritoneal ultrafiltration. J Am Soc Nephrol 2005;16:546.